Novavine – Trademark Portfolio

Entity Type: 03

Novavine owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as NOVAVINE, NOVA VINEYARDS, GOJI PHYTO-BREW, and GOJI FARM U.S.A.. Of these, 4 are registered. The portfolio spans 3 Nice Classification classes, led by Class 32 (Light Beverages) and Class 31 (Natural Agricultural Products). Headquartered in Santa Rosa, CA.

6735 Sonoma Highway

Santa Rosa, CA 95409

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Novavine's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

32
Light Beverages (2 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

31
Natural Agricultural Products (2 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

33
Wine & Spirits (1 filing)

Alcoholic beverages (except beers)

Frequently Asked Questions

How many trademarks does Novavine have?

Novavine has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 cancelled.

What trademark classes does Novavine file in?

Novavine files trademarks across 3 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 31 (Natural Agricultural Products), Class 33 (Wine & Spirits). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.

What are Novavine's most well-known trademarks?

Novavine's registered trademark portfolio includes well-known marks such as NOVAVINE, NOVA VINEYARDS, GOJI PHYTO-BREW, and GOJI FARM U.S.A.. These are among 4 currently registered trademarks in the portfolio.

What is Novavine's trademark registration success rate?

Novavine has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.